General Information

Bromfenac was cleared for marketing by the FDA on July 15, 1997. This provides an alternative to opioids for the management of acute pain. Bromfenac provides fast relief of acute pain without the side effects of opioid analgesics.

Side Effects

Possible adverse side effects include abdominal pain, headache, nausea, and vomiting.